Search Results - "Mattiuz, Giorgio"

The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas by Saraconi, Giulia, Severi, Francesco, Sala, Cesare, Mattiuz, Giorgio, Conticello, Silvestro G

“…The AID/APOBECs are deaminases that act on cytosines in a diverse set of pathways and some of them have been linked to the onset of genetic alterations in…”
Get full text

Effects of common Gram-negative pathogens causing male genitourinary-tract infections on human sperm functions by Marchiani, Sara, Baccani, Ilaria, Tamburrino, Lara, Mattiuz, Giorgio, Nicolò, Sabrina, Bonaiuto, Chiara, Panico, Carmen, Vignozzi, Linda, Antonelli, Alberto, Rossolini, Gian Maria, Torcia, Maria, Baldi, Elisabetta

“…Male genitourinary tract (MGT) bacterial infections are considered responsible for 15% of male infertility, but the mechanisms underlying decreased semen…”
Get full text

An elusive debate on the evidence for RNA editing in SARS-CoV-2 by Mattiuz, Giorgio, Di Giorgio, Salvatore, Conticello, Silvestro G

Get full text

Vaginal Lactobacilli and Vaginal Dysbiosis-Associated Bacteria Differently Affect Cervical Epithelial and Immune Homeostasis and Anti-Viral Defenses by Nicolò, Sabrina, Tanturli, Michele, Mattiuz, Giorgio, Antonelli, Alberto, Baccani, Ilaria, Bonaiuto, Chiara, Baldi, Simone, Nannini, Giulia, Menicatti, Marta, Bartolucci, Gianluca, Rossolini, Gian Maria, Amedei, Amedeo, Torcia, Maria Gabriella

“…Persistent infection with High Risk-Human Papilloma Viruses (HR-HPVs) is a primary cause of cervical cancer worldwide. Vaginal-dysbiosis-associated bacteria…”
Get full text

Author Correction: Effects of common Gram-negative pathogens causing male genitourinary-tract infections on human sperm functions by Marchiani, Sara, Baccani, Ilaria, Tamburrino, Lara, Mattiuz, Giorgio, Nicolò, Sabrina, Bonaiuto, Chiara, Panico, Carmen, Vignozzi, Linda, Antonelli, Alberto, Rossolini, Gian Maria, Torcia, Maria, Baldi, Elisabetta

Get full text

COVID-19 annual update: a narrative review by Biancolella, Michela, Colona, Vito Luigi, Luzzatto, Lucio, Watt, Jessica Lee, Mattiuz, Giorgio, Conticello, Silvestro G, Kaminski, Naftali, Mehrian-Shai, Ruty, Ko, Albert I, Gonsalves, Gregg S, Vasiliou, Vasilis, Novelli, Giuseppe, Reichardt, Juergen K V

“…Three and a half years after the pandemic outbreak, now that WHO has formally declared that the emergency is over, COVID-19 is still a significant global…”
Get full text

Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents by Raddi, Marco G., Bencini, Sara, Peruzzi, Benedetta, Mattiuz, Giorgio, De Pourcq, Sven, Tanturli, Michele, Chapuis, Nicolas, Consagra, Angela, Rigodanza, Luca, Amato, Cristina, Sanna, Alessandro, Tofacchi, Elena, Attardi, Enrico, Park, Sophie, Kosmider, Olivier, Annunziato, Francesco, Fontenay, Michaela, Santini, Valeria

Get full text

Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes by Attardi, Enrico, Tiberi, Lucia, Mattiuz, Giorgio, Formicola, Daniela, Dirupo, Elia, Raddi, Marco G., Consagra, Angela, Vergani, Debora, Artuso, Rosangela, Santini, Valeria

“…Relevance of germline (GL) predisposition in myelodysplastic syndromes (MDSs) was stressed in both 2022 WHO and International Consensus classifications, but…”
Get full text

Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cells by Sala, Cesare, Mattiuz, Giorgio, Pietrobono, Silvia, Chicca, Andrea, Conticello, Silvestro G

“…Activation Induced Deaminase (AID) triggers the antigen-driven antibody diversification processes through its ability to edit DNA. AID dependent DNA damage is…”
Get full text

Hypervirulent Klebsiella pneumoniae Strains Modulate Human Dendritic Cell Functions and Affect TH1/TH17 Response by Nicolò, Sabrina, Mattiuz, Giorgio, Antonelli, Alberto, Arena, Fabio, Di Pilato, Vincenzo, Giani, Tommaso, Baccani, Ilaria, Clemente, Ann Maria, Castronovo, Giuseppe, Tanturli, Michele, Cozzolino, Federico, Rossolini, Gian Maria, Torcia, Maria Gabriella

“…Hypervirulent Klebsiella pneumoniae (Hv-Kp) strains have emerged as pathogens causing life-threatening, invasive disease even in immunocompetent hosts…”
Get full text

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2 by Di Giorgio, Salvatore, Martignano, Filippo, Torcia, Maria Gabriella, Mattiuz, Giorgio, Conticello, Silvestro G

“…The COVID-19 outbreak has become a global health risk, and understanding the response of the host to the SARS-CoV-2 virus will help to combat the disease. RNA…”
Get full text

Treatment with Oral Azacitidine in Elderly Patients with Higher Risk Myelodysplastic Syndromes after Response to Subcutaneous Azacitidine by Santini, Valeria, Amato, Cristina, Caciagli, Barbara, Consagra, Angela, Rigodanza, Luca, de Pourcq, Sven, Cassari, Margherita, Tofacchi, Elena, Mattiuz, Giorgio, Raddi, Marco Gabriele Gabriele, Sanna, Alessandro

Get full text

The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens by Consagra, Angela, Sanna, Alessandro, Raddi, Marco Gabriele, Rigodanza, Luca, Attardi, Enrico, Amato, Cristina, Cassari, Margherita, Tofacchi, Elena, Mattiuz, Giorgio, de Pourcq, Sven, Santini, Valeria

Get full text

TP53 VAF as an Easier Prognostic Indicator in Myelodysplastic Neoplasms in Comparison With Tp53 Allelic Status by Rigodanza, Luca, Andreossi, Gloria, Consagra, Angela, Sanna, Alessandro, Mattiuz, Giorgio, Jiulien Maria de Pourcq, Sven, Gabriele Raddi, Marco, Santini, Valeria

Get full text

MDS-679 TP53 VAF as an Easier Prognostic Indicator in Myelodysplastic Neoplasms in Comparison With Tp53 Allelic Status by Rigodanza, Luca, Andreossi, Gloria, Consagra, Angela, Sanna, Alessandro, Mattiuz, Giorgio, de Pourcq, Sven Jiulien Maria, Gabriele Raddi, Marco, Santini, Valeria

“…Biallelic TP53 inactivation negatively affects overall survival (OS) and leukemia-free survival (LFS) of patients with myelodysplastic syndromes (MDS), whereas…”
Get full text

Treatment of Elderly Patients with Higher Risk Myelodysplastic Syndromes with Oral Azacitidine by Santini, Valeria, Amato, Cristina, De Pourcq, Sven, della Seta, Roberta, Caciagli, Barbara, Raddi, Marco Gabriele, Consagra, Angela, Rigodanza, Luca, Mattiuz, Giorgio, Defina, Marzia, Galimberti, Sara, Maestrini, Giacomo, Sanna, Alessandro

“…Background Oral formulations ofhypomethylating agents decitabine (ASTX727) and azacitidine (cc-486, AZA) were approved respectively for treatment of higher…”
Get full text

Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes by Raddi, Marco Gabriele Gabriele, Bencini, Sara, Peruzzi, Benedetta, Caporale, Roberto, Consagra, Angela, Attardi, Enrico, Rigodanza, Luca, Amato, Cristina, Sanna, Alessandro, Brogi, Alice, Tofacchi, Elena, Cassari, Margherita, de Pourcq, Sven, Mattiuz, Giorgio, Annunziato, Francesco, Santini, Valeria

Get full text

Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms by Raddi, Marco Gabriele, Consagra, Angela, Rigodanza, Luca, Amato, Cristina, Sanna, Alessandro, Mattiuz, Giorgio, De Pourcq, Sven, Tofacchi, Elena, Diez-Campelo, Maria, Caballero Berrocal, Juan Carlos, Park, Sophie, Meunier, Mathieu, Orlando, Celia, Fontenay, Michaela, Kosmider, Olivier, Chapuis, Nicolas, Platzbecker, Uwe, Zoldan, Katharina, Kubasch, Anne Sophie, Santini, Valeria

“…INTRODUCTION Lower risk myelodysplastic neoplasms (LR-MDS), as defined by IPSS-R, are frequently presenting with anemia which is primarily treated with…”
Get full text

POSTER: MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M by Rigodanza, Luca, Consagra, Angela, Alessandro, Sanna, Cassari, Margherita, Tofacchi, Elena, de Pourcq, Sven Jiulien Maria, Mattiuz, Giorgio, Amato, Cristina, Raddi, Marco Gabriele, Santini, Valeria

Get full text

MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M by Rigodanza, Luca, Consagra, Angela, Alessandro, Sanna, Cassari, Margherita, Tofacchi, Elena, de Pourcq, Sven Jiulien Maria, Mattiuz, Giorgio, Amato, Cristina, Raddi, Marco Gabriele, Santini, Valeria

“…Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemic low-risk myelodysplastic syndrome (MDS) patients. Response to these agents is…”
Get full text